(MGA) Magna International - Overview
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA5592224011
Stock: Automotive Parts, Vehicle Systems, Electronics, Powertrain, Seating
Total Rating 65
Risk 80
Buy Signal 0.10
| Risk 5d forecast | |
|---|---|
| Volatility | 35.5% |
| Relative Tail Risk | -12.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.60 |
| Alpha | 70.59 |
| Character TTM | |
|---|---|
| Beta | 0.735 |
| Beta Downside | 0.727 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.57% |
| CAGR/Max DD | 0.17 |
EPS (Earnings per Share)
Revenue
Description: MGA Magna International March 04, 2026
Magna International Inc. is an automotive supplier with operations in vehicle engineering, contract manufacturing, and automotive components. The companys business model is diversified across four segments: Body Exteriors & Structures, Power & Vision, Seating Systems, and Complete Vehicles.
MGA manufactures a wide array of products, including battery enclosures, chassis systems, advanced driver-assistance systems (ADAS) components like cameras and radar, and various body and exterior parts such as lighting and liftgate modules. The company also produces seating systems, eDrive systems, and powertrain components for both hybrid and internal combustion engine vehicles. The automotive parts and equipment sector is characterized by a complex supply chain and significant capital investment in manufacturing.
Founded in 1957 and headquartered in Aurora, Canada, MGA has a long history in the automotive industry. To gain deeper insights into Magnas market position and financial health, further research on ValueRay is recommended.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 829.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 2.17 > 1.0 |
| NWC/Revenue: 6.51% < 20% (prev 2.38%; Δ 4.12% < -1%) |
| CFO/TA 0.12 > 3% & CFO 3.63b > Net Income 829.0m |
| Net Debt (6.71b) to EBITDA (3.83b): 1.75 < 3 |
| Current Ratio: 1.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (281.2m) vs 12m ago -1.64% < -2% |
| Gross Margin: 13.23% > 18% (prev 0.14%; Δ 1309 % > 0.5%) |
| Asset Turnover: 135.2% > 50% (prev 138.0%; Δ -2.82% > 0%) |
| Interest Coverage Ratio: 10.07 > 6 (EBITDA TTM 3.83b / Interest Expense TTM 209.6m) |
Altman Z'' 2.74
| A: 0.09 (Total Current Assets 13.71b - Total Current Liabilities 10.97b) / Total Assets 31.36b |
| B: 0.31 (Retained Earnings 9.75b / Total Assets 31.36b) |
| C: 0.07 (EBIT TTM 2.11b / Avg Total Assets 31.20b) |
| D: 0.66 (Book Value of Equity 12.33b / Total Liabilities 18.54b) |
| Altman-Z'' Score: 2.74 = A |
Beneish M -3.09
| DSRI: 1.04 (Receivables 7.58b/7.38b, Revenue 42.18b/42.84b) |
| GMI: 1.02 (GM 13.23% / 13.54%) |
| AQI: 0.96 (AQ_t 0.20 / AQ_t-1 0.21) |
| SGI: 0.98 (Revenue 42.18b / 42.84b) |
| TATA: -0.09 (NI 829.0m - CFO 3.63b) / TA 31.36b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
What is the price of MGA shares?
As of March 06, 2026, the stock is trading at USD 60.90 with a total of 1,226,467 shares traded.
Over the past week, the price has changed by -4.33%, over one month by +16.57%, over three months by +25.18% and over the past year by +72.52%.
Over the past week, the price has changed by -4.33%, over one month by +16.57%, over three months by +25.18% and over the past year by +72.52%.
Is MGA a buy, sell or hold?
Magna International has received a consensus analysts rating of 3.20.
Therefor, it is recommend to hold MGA.
- StrongBuy: 1
- Buy: 4
- Hold: 13
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the MGA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 67.8 | 11.3% |
| Analysts Target Price | 67.8 | 11.3% |
MGA Fundamental Data Overview March 05, 2026
P/E Trailing = 21.0853
P/E Forward = 9.3809
P/S = 0.4139
P/B = 1.4102
P/EG = 0.5061
Revenue TTM = 42.18b USD
EBIT TTM = 2.11b USD
EBITDA TTM = 3.83b USD
Long Term Debt = 4.97b USD (from longTermDebt, two quarters ago)
Short Term Debt = 354.4m USD (from shortTermDebt, last quarter)
Debt = 8.32b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.71b USD (from netDebt column, last quarter)
Enterprise Value = 24.10b USD (17.39b + Debt 8.32b - CCE 1.61b)
Interest Coverage Ratio = 10.07 (Ebit TTM 2.11b / Interest Expense TTM 209.6m)
EV/FCF = 11.21x (Enterprise Value 24.10b / FCF TTM 2.15b)
FCF Yield = 8.92% (FCF TTM 2.15b / Enterprise Value 24.10b)
FCF Margin = 5.10% (FCF TTM 2.15b / Revenue TTM 42.18b)
Net Margin = 1.97% (Net Income TTM 829.0m / Revenue TTM 42.18b)
Gross Margin = 13.23% ((Revenue TTM 42.18b - Cost of Revenue TTM 36.60b) / Revenue TTM)
Gross Margin QoQ = 12.21% (prev 14.23%)
Tobins Q-Ratio = 0.77 (Enterprise Value 24.10b / Total Assets 31.36b)
Interest Expense / Debt = 0.51% (Interest Expense 42.6m / Debt 8.32b)
Taxrate = 32.49% (432.4m / 1.33b)
NOPAT = 1.42b (EBIT 2.11b * (1 - 32.49%))
Current Ratio = 1.25 (Total Current Assets 13.71b / Total Current Liabilities 10.97b)
Debt / Equity = 0.67 (Debt 8.32b / totalStockholderEquity, last quarter 12.47b)
Debt / EBITDA = 1.75 (Net Debt 6.71b / EBITDA 3.83b)
Debt / FCF = 3.12 (Net Debt 6.71b / FCF TTM 2.15b)
Total Stockholder Equity = 12.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.66% (Net Income 829.0m / Total Assets 31.36b)
RoE = 6.73% (Net Income TTM 829.0m / Total Stockholder Equity 12.32b)
RoCE = 12.21% (EBIT 2.11b / Capital Employed (Equity 12.32b + L.T.Debt 4.97b))
RoIC = 7.94% (NOPAT 1.42b / Invested Capital 17.93b)
WACC = 5.95% (E(17.39b)/V(25.71b) * Re(8.63%) + D(8.32b)/V(25.71b) * Rd(0.51%) * (1-Tc(0.32)))
Discount Rate = 8.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF] Terminal Value 88.26% ; FCFF base≈1.87b ; Y1≈2.31b ; Y5≈3.93b
[DCF] Fair Price = 380.2 (EV 112.70b - Net Debt 6.71b = Equity 105.99b / Shares 278.8m; r=5.95% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 47.01 | EPS CAGR: 15.26% | SUE: 2.37 | # QB: 1
Revenue Correlation: 61.65 | Revenue CAGR: 3.61% | SUE: 4.0 | # QB: 5
EPS next Quarter (2026-06-30): EPS=1.62 | Chg7d=-0.007 | Chg30d=+0.146 | Revisions Net=+6 | Analysts=13
EPS current Year (2026-12-31): EPS=6.75 | Chg7d=+0.038 | Chg30d=+0.775 | Revisions Net=+16 | Growth EPS=+17.8% | Growth Revenue=+1.4%
EPS next Year (2027-12-31): EPS=7.62 | Chg7d=+0.044 | Chg30d=+0.847 | Revisions Net=+6 | Growth EPS=+12.8% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: +1.00 (6 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.9% (Discount Rate 8.6% - Earnings Yield 4.7%)
[Growth] Growth Spread = -3.2% (Analyst 0.7% - Implied 3.9%)
P/E Forward = 9.3809
P/S = 0.4139
P/B = 1.4102
P/EG = 0.5061
Revenue TTM = 42.18b USD
EBIT TTM = 2.11b USD
EBITDA TTM = 3.83b USD
Long Term Debt = 4.97b USD (from longTermDebt, two quarters ago)
Short Term Debt = 354.4m USD (from shortTermDebt, last quarter)
Debt = 8.32b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.71b USD (from netDebt column, last quarter)
Enterprise Value = 24.10b USD (17.39b + Debt 8.32b - CCE 1.61b)
Interest Coverage Ratio = 10.07 (Ebit TTM 2.11b / Interest Expense TTM 209.6m)
EV/FCF = 11.21x (Enterprise Value 24.10b / FCF TTM 2.15b)
FCF Yield = 8.92% (FCF TTM 2.15b / Enterprise Value 24.10b)
FCF Margin = 5.10% (FCF TTM 2.15b / Revenue TTM 42.18b)
Net Margin = 1.97% (Net Income TTM 829.0m / Revenue TTM 42.18b)
Gross Margin = 13.23% ((Revenue TTM 42.18b - Cost of Revenue TTM 36.60b) / Revenue TTM)
Gross Margin QoQ = 12.21% (prev 14.23%)
Tobins Q-Ratio = 0.77 (Enterprise Value 24.10b / Total Assets 31.36b)
Interest Expense / Debt = 0.51% (Interest Expense 42.6m / Debt 8.32b)
Taxrate = 32.49% (432.4m / 1.33b)
NOPAT = 1.42b (EBIT 2.11b * (1 - 32.49%))
Current Ratio = 1.25 (Total Current Assets 13.71b / Total Current Liabilities 10.97b)
Debt / Equity = 0.67 (Debt 8.32b / totalStockholderEquity, last quarter 12.47b)
Debt / EBITDA = 1.75 (Net Debt 6.71b / EBITDA 3.83b)
Debt / FCF = 3.12 (Net Debt 6.71b / FCF TTM 2.15b)
Total Stockholder Equity = 12.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.66% (Net Income 829.0m / Total Assets 31.36b)
RoE = 6.73% (Net Income TTM 829.0m / Total Stockholder Equity 12.32b)
RoCE = 12.21% (EBIT 2.11b / Capital Employed (Equity 12.32b + L.T.Debt 4.97b))
RoIC = 7.94% (NOPAT 1.42b / Invested Capital 17.93b)
WACC = 5.95% (E(17.39b)/V(25.71b) * Re(8.63%) + D(8.32b)/V(25.71b) * Rd(0.51%) * (1-Tc(0.32)))
Discount Rate = 8.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.95%
[DCF] Terminal Value 88.26% ; FCFF base≈1.87b ; Y1≈2.31b ; Y5≈3.93b
[DCF] Fair Price = 380.2 (EV 112.70b - Net Debt 6.71b = Equity 105.99b / Shares 278.8m; r=5.95% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 47.01 | EPS CAGR: 15.26% | SUE: 2.37 | # QB: 1
Revenue Correlation: 61.65 | Revenue CAGR: 3.61% | SUE: 4.0 | # QB: 5
EPS next Quarter (2026-06-30): EPS=1.62 | Chg7d=-0.007 | Chg30d=+0.146 | Revisions Net=+6 | Analysts=13
EPS current Year (2026-12-31): EPS=6.75 | Chg7d=+0.038 | Chg30d=+0.775 | Revisions Net=+16 | Growth EPS=+17.8% | Growth Revenue=+1.4%
EPS next Year (2027-12-31): EPS=7.62 | Chg7d=+0.044 | Chg30d=+0.847 | Revisions Net=+6 | Growth EPS=+12.8% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: +1.00 (6 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.9% (Discount Rate 8.6% - Earnings Yield 4.7%)
[Growth] Growth Spread = -3.2% (Analyst 0.7% - Implied 3.9%)